Report Categories
View AllRecent Articles
View All
GAINI Gladstone reports Q1 2026 EPS below analyst estimates even as shares tick marginally higher today
What makes Assertio ASRT a safer bet than newer entrants 077 20260508
Regeneron Pharmaceuticals Inc REGN Bullish Analyst Ratings Underscore Oncology Pipeline Upside and Core Product Resilience
TONX TON posts narrower than expected Q3 2025 loss shares edge down 142 in todays session